Nicholas Laccona's Insider Trades & SAST Disclosures
Nicholas Laccona's most recent trade in Bellerophon Therapeutics Inc was a trade of 50,000 Stock Options (right to buy) done . Disclosure was reported to the exchange on Feb. 10, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Nicholas Laccona.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bellerophon Therapeutics Inc | Nicholas Laccona | FINANCIAL OFFICER, (PFO & PAO) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 50,000 | 50,000 | - | - | Stock Options (right to buy) | |
| Bellerophon Therapeutics Inc | Nicholas Laccona | FINANCIAL OFFICER, (PFO & PAO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 18,000 | 18,000 | - | - | Restricted Stock Units | |
| Bellerophon Therapeutics Inc | Nicholas Laccona | FINANCIAL OFFICER, (PFO & PAO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 18,000 | 18,000 (0%) | 0% | - | Common Stock | |
| Bellerophon Therapeutics Inc | Nicholas Laccona | FINANCIAL OFFICER, (PFO & PAO) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. | 09 Dec 2022 | 5,530 | 12,470 (0%) | 0% | 0.9 | 5,143 | Common Stock |
| Bellerophon Therapeutics Inc | Nicholas Laccona | FINANCIAL OFFICER, (PFO & PAO) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 36,000 | 36,000 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges